홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-Methylmorpholine → N-{[4-((2R,3R)-1-(4-Fluorophenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycylglycine

HRID 254080
인쇄

반응식

HRID 254080 반응식
[F:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[C:11](=[O:12])[C@H:10]([S:13][CH2:14][C:15]([C:17]3[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=3)=[O:16])[C@H:9]2[C:24]2[CH:34]=[CH:33][C:27]([O:28][CH2:29]C(O)=O)=[CH:26][CH:25]=2)=[CH:4][CH:3]=1.Cl.C[O:37][C:38](=[O:45])[CH2:39][NH:40][C:41](=[O:44])[CH2:42][NH2:43].CN1CC[O:50][CH2:49]C1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.C1CN2C(=NCCC2)C1.C([O-])(=O)C.[NH4+]>C(Cl)Cl>[F:1][C:2]1[CH:3]=[CH:4][C:5]([N:8]2[C:11](=[O:12])[C@H:10]([S:13][CH2:14][C:15]([C:17]3[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=3)=[O:16])[C@H:9]2[C:24]2[CH:25]=[CH:26][C:27]([O:28][CH2:29][C:49]([NH:43][CH2:42][C:41]([NH:40][CH2:39][C:38]([OH:37])=[O:45])=[O:44])=[O:50])=[CH:33][CH:34]=2)=[CH:6][CH:7]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 6

HCID 79724-MethylmorpholineHCID 763491,5-Diazabicyclo(4.3.0)non-5-eneHCID 517165Ammonium AcetateHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 13029724Methyl 2-(2-aminoacetamido)acetate hydrochlorideHCID 66842813
[4-((2R,3R)-1-(4-Fluorophenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetic acid

생성물 1

HCID 66843038N-{[4-((2R,3R)-1-(4-Fluorophenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycylglycine수율 38%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

A solution of [4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetic acid (0.200 g, 0.414 mmol), glycylglycine methyl ester hydrochloride (0.090 g, 0.493 mmol) and N-methylmorpholine (0.150 ml) in DCM (5 ml) was stirred for 10 min. TBTU (0.170 g) was added and the mixture was stirred for 20 h. The formation of the ester was confirmed. M/z: 612.0. The solvent was removed under reduced pressure. The residue was dissolved in a mixture of MeOH (5 ml), water (1 ml) and Et3N (0.5 ml). The solution was stirred at 50° C. for 18 h. DBN (0.050 ml, 0.405 mmol) was added and the mixture was stirred for 2 h at 50° C. Ammonium acetate buffer (0.1 M, 3 ml) was added and the mixture was concentrated. The residue was purified by preparative HPLC, using a gradient of 20-50% MeCN in 0.1M ammonium acetate buffer as eluent. After freeze-drying, the title product (0.094 g, 38% yield) was obtained as a white solid. M/z: 598.2. 1H NMR (DMSO, 400 MHz): 3.50 (d, 2H), 3.75 (d, 2H), 4.32 (d, 1H), 4.35 (ABq, 2H), 4.46-4.53 (m, 2H), 5.15 (d, 1H), 6.94-7.00 (m, 2H), 7.10-7.25 (m, 4H), 7.29-7.39 (m, 4H), 7.68-7.81 (m, 1H), 7.98-8.04 (m, 2H), 8.30-8.36 (m, 1).

후처리

  1. customThe solvent was removed under reduced pressure
  2. dissolutionThe residue was dissolved in a mixture of MeOH (5 ml), water (1 ml) and Et3N (0.5 ml)
  3. stirringThe solution was stirred at 50° C. for 18 h
  4. stirringthe mixture was stirred for 2 h at 50° C
  5. concentrationthe mixture was concentrated
  6. customThe residue was purified by preparative HPLC
  7. customAfter freeze-drying

출처 및 근거

ORD 기록
ord-a926c66c234046b0b06cfe4cdcaae2c6
출처 데이터셋
uspto-grants-2011_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07871998B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트